Emilio Merlo

Emilio Merlo Pich, MD, is a neurologist and neurobiologist with expertise in Pharma R&D and interest in developing new treatments for nervous system disorders. In the last 20 years he has been engaged in various roles related to biomarkers and early clinical development in the Neuroscience Therapeutic Area, at first in GlaxoSmithKline and its legacy company Glaxo-Wellcome, where he led the Experimental Medicine and Molecular Medicine functions, and more recently, in F. Hoffman- La Roche, Basel Switzerland, where he was in charge of CNS Biomarkers and Imaging. He graduated in Bologna, Italy and was in academia at the University of Modena, at Karolinska Istitutet of Stockholm, Mario Negri, Milan, and at the Scripps Research Institute, La Jolla. Emilio Merlo Pich is co-author of more than 200 publications. He received several awards throughout his career and he is Fellow of the American College of Neuropsychopharmacology (ACNP).